This federal Project Grant award of $2,940,000.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports research by the University of Connecticut Health Center (UCHC) to transform care for extremity composite injuries through innovations in regenerative medicine and translational research. The award, effective from November 1, 2024 to October 31, 2027, will fund UCHC's efforts to develop advanced medical solutions for military...
This $361,679 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research conducted by the University of Connecticut (UConn). The funding will enable UConn to develop dual-function biomaterials for the treatment of interstitial cystitis, a chronic bladder condition, over a 2-year period from March 2025 to February 2027. The research aims to transform healthcare for military service...
The Defense Health Agency awarded a $1,061,440 Project Grant to the University of South Florida (USF) on September 1, 2023 under the Military Medical Research and Development (CFDA 12.420) program. This 3-year grant will support USF's development of an artificial cornea and sensor-based continuous intraocular pressure (IOP) monitoring system to treat patients with cornea blindness secondary to war-related ocular injuries. The products and services to be delivered through this grant include...
The University of Connecticut Health Center (UCHC) was awarded a $578,891 Project Grant from the Office of the Secretary of Defense for the period of August 1, 2023 to July 31, 2026. This award is funded under the Basic Scientific Research program (CFDA 12.431), which supports basic research related to or with the potential to improve Army programs or operations. The grant will support UCHC's research project titled "MULTI-PHYSICS MULTI-SCALE FUNDAMENTAL UNDERSTANDING OF PATHOLOGICAL...
The University of Connecticut Health Center was awarded a $984,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund research into a novel signaling pathway to promote oligodendrocyte maturation leading to a new treatment for multiple sclerosis. The goal of the Military Medical Research and Development program is to transform military and public health through innovative medical research...
This $1,622,955 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research and development of a novel therapeutic agent called LACRIPEP for corneal wound healing and ocular surface homeostasis. The grant was awarded on September 15, 2024 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit research organization, with a performance period ending on September 14,...
This Project Grant award, with a total funding of $5,963,305.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the continued clinical development of a novel pleural and tracheal sealant. The primary award recipient is the University of Vermont & State Agricultural College. A sub-award of an unspecified amount was provided to the University of Connecticut Health Center to support this research effort. The funding will...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...
This Project Grant award, totaling $435,465.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports in-situ use of acoustic radiation force and cell therapy to heal large-scale cranial defects. The primary awardee is the University of Connecticut Health Center, which will design experiments, perform in vitro and in vivo laboratory work, supervise lab personnel, analyze data, and draft publications and...
The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...